Circular RNAs (circRNAs), as with other noncoding RNAs, have emerged as novel molecules of interest in gene regulation and in the development of many diseases. However, the expression and function of circRNAs in inflammation-induced lymphangiogenesis (LG) are still unknown. Microarray profiling in inflamed human lymphatic endothelial cells identified 82 differentially expressed circRNAs, including 6 downregulated and 76 upregulated circRNAs. One of the top 10 upregulated circRNAs, cZNF609, was selected for subsequent quantitative real-time PCR validation, and was found to be significantly upregulated in inflamed corneas from both mouse and human eyes. The expression of miR-184 was significantly lower in inflamed corneas than in control ones, which suggested that cZNF609 might serve as a sponge for miR-184. The expression of heparanase, a potential target gene of miR-184, was significantly increased in inflamed corneas. Therefore, circRNAs may serve as potential regulators of corneal LG. These findings lay a foundation for functional research on circRNAs in corneal LG pathogenesis.
Get full access to this article
View all access options for this article.
References
1.
Abu El-AsrarA.M., SiddiqueiM.M., NawazM.I., De HertoghG., MohammadG., and AlamK., et al. (2016). Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy. Mol Vis, 22, 424–435.
2.
AmbrosV. (2004). The functions of animal microRNAs. Nature, 431, 350–355.
3.
Bachmayr-HeydaA., ReinerA.T., AuerK., SukhbaatarN., AustS., Bachleitner-HofmannT., et al. (2015). Correlation of circular RNA abundance with proliferation—exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep, 5, 8057.
4.
BoeckelJ.N., JaéN., HeumüllerA.W., ChenW., BoonR.A., StellosK., et al. (2015). Identification and characterization of hypoxia-regulated endothelial circular RNA. Circ Res, 117, 884–890.
5.
ChenL.L. (2016). The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol, 17, 205–211.
Cohen-KaplanV., NaroditskyI., ZetserA., IlanN., VlodavskyI., and DoweckI. (2008). Heparanase induces VEGF C and facilitates tumor lymphangiogenesis. Int J Cancer, 123, 2566–2573.
8.
ConnS.J., PillmanK.A., ToubiaJ., ConnV.M., SalmanidisM., PhillipsC.A., et al. (2015). The RNA binding protein quaking regulates formation of circRNAs. Cell, 160, 1125–1134.
9.
DetryB., BlacherS., ErpicumC., PaupertJ., MaertensL., MaillardC., et al. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest Ophthalmol Vis Sci, 54, 3082–3093.
10.
DuL.L., and LiuP. (2016). CXCL12/CXCR4 axis regulates neovascularization and lymphangiogenesis in sutured corneas in mice. Mol Med Rep, 13, 4987–4994.
11.
EllenbergD., AzarD.T., HallakJ.A., TobaigyF., HanK.Y., JainS., et al. (2010). Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res, 29, 208–248.
12.
GiacominiC., FerrariG., BignamiF., and RamaP. (2014). Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization. Exp Eye Res, 121, 1–4.
13.
GoyalS., ChauhanS.K., and DanaR. (2012). Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease. Arch Ophthalmol, 130, 84–89.
14.
GrimaldoS., YuenD., TheisJ., NgM., EcoiffierT., and ChenL. (2015). MicroRNA-184 regulates corneal lymphangiogenesis. Invest Ophthalmol Vis Sci, 56, 7209–7213.
15.
HammondS.M. (2015). An overview of microRNAs. Adv Drug Deliv Rev, 87, 3–14.
16.
HuJ., WangJ., LengX., HuY., ShenH., and SongX. (2017). Heparanase mediates vascular endothelial growth factor gene transcription in high-glucose human retinal microvascular endothelial cells. Mol Vis, 23, 579–587.
17.
LeeH.S., HosD., BlancoT., BockF., ReyesN.J., MathewR., et al. (2015). Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease. Invest Ophthalmol Vis Sci, 56, 3140–3148.
18.
LiaoS., and von der WeidP.Y. (2014). Inflammation-induced lymphangiogenesis and lymphatic dysfunction. Angiogenesis, 17, 325–334.
LiuC., YaoM.D., LiC.P., ShanK., YangH., WangJ.J., et al. (2017). Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics, 7, 2863–2877.
21.
MaruyamaK., IiM., CursiefenC., JacksonD.G., KeinoH., TomitaM., et al. (2005). Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest, 115, 2363–2372.
22.
MylerH.A., and WestJ.L. (2002). Heparanase and platelet factor-4 induce smooth muscle cell proliferation and migration via bFGF release from the ECM. J Biochem, 131, 913–922.
23.
PoupardN., BadarouP., FasaniF., GroultH., BridiauN., SannierF., et al. (2017). Assessment of heparanase-mediated angiogenesis using microvascular endothelial cells: identification of λ-carrageenan derivative as a potent anti angiogenic agent. Mar Drugs, 15, E134.
24.
RyanD.G., Oliveira-FernandesM., and LavkerR.M. (2006). MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis, 12, 1175–1184.
25.
SavetskyI.L., GhantaS., GardenierJ.C., TorrisiJ.S., García NoresG.D., HespeG.E., et al. (2015). Th2 cytokines inhibit lymphangiogenesis. PLoS One, 10, e0126908.
ShiW., MingC., LiuJ., WangT., and GaoH. (2011). Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice. Graefes Arch Clin Exp Ophthalmol, 249, 55–67.
28.
ShinK., and LeeS.H. (2014). Interplay between inflammatory responses and lymphatic vessels. Immune Netw, 14, 182–186.
29.
TammelaT., and AlitaloK. (2010). Lymphangiogenesis: molecular mechanisms and future promise. Cell, 140, 460–476.
30.
WatariK., NakaoS., FotovatiA., BasakiY., HosoiF., BereczkyB., et al. (2008). Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun, 377, 826–831.
31.
WuestT.R., and CarrD.J. (2010). VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med, 207, 101–115.
32.
YanZ., JiangT., WangP., HuangX., YangQ., SunW., et al. (2018). Circular RNA expression profile of spleen in a Clostridium perfringens type C-induced piglet model of necrotizing enteritis. FEBS Open Bio, 8, 1722–1732.
33.
YouX., VlatkovicI., BabicA., WillT., EpsteinI., TushevG, et al. (2015). Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci, 18, 603–610.
34.
ZhengF., YuX., HuangJ., and DaiY. (2017). Circular RNA expression profiles of peripheral blood mononuclear cells in rheumatoid arthritis patients, based on microarray chip technology. Mol Med Rep, 16, 8029–8036.
35.
ZhongZ., LvM., and ChenJ. (2016). Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci Rep, 6, 30919.
36.
ZhouR., WuY., WangW., SuW., LiuY., WangY., et al. (2018a). Circular RNAs (circRNAs) in cancer. Cancer Lett, 425, 134–142.
37.
ZhouZ., DuD., ChenA., and ZhuL. (2018b). Circular RNA expression profile of articular chondrocytes in an IL-1β-induced mouse model of osteoarthritis. Gene, 644, 20–26.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
